Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients

Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukemia (CML) into a manageable disease, and discontinuation has become a feasible goal for many patients. However, molecular relapse after TKI cessation remains a challenge. This study investigated factors influencing molecular rel...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Bianca Vasconcelos Cordoba, Carolina Pavlovsky, María Belén Sanchez, Elena Beatriz Moiraghi, Ana Ines Varela, Miguel Arturo Pavlovsky, Isabel Amanda Giere, Franco Federico Freilich, Isolda Fernandez, Maria José Mela Osório, Ricardo Khalil Tannuri, Federico Sackmann, Mariana Juni, Georgina Emilia Bendek Del Prete, Eduardo Oscar Bullorsky, Juan Dupont, Josefina Freitas, Verónica Ventriglia, Ana Garcia Labanca, Romina Mariano, Carina Gumpel, Etelvina Macchiavello, Pedro Negri Aranguren, Mariano Paoletti, Francisca Rojas, Maria Fernanda Tosin, Marta Catalan, Maria del Rosario Custidiano, Maria Cecilia Foncuberta, Julio Cesar Sánchez Ávalos, Silvia Miranda, José Mordoh, Estrella Mariel Levy, Michele Bianchini
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2026-04-01
سلاسل:	Cells
الموضوعات:	chronic myeloid leukemia treatment-free remission cytokine profiling immune biomarkers MCP-1 IL-6
الوصول للمادة أونلاين:	https://www.mdpi.com/2073-4409/15/9/791
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!